01 5GE Healthcare Inc
01 1BEREDNINGSSATS FÖR RADIOAKTIVT LÄKEMEDEL
02 2POWDER FOR SOLUTION
03 1Tetrofosmina 0.23Mg 2 Units Parenteral Use
04 1Tetrofosmina 0.23Mg 5 Units Parenteral Use
01 2Schedule C
02 3Blank
01 1MYOVIEW
02 1MYOVIEW 30ML
03 3Myoview
01 2Canada
02 2Italy
03 1Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Myoview
Dosage Form : BEREDNINGSSATS FÖR RADIOAKTIVT LÄKEMEDEL
Dosage Strength : 230 MIKROGRAM
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Myoview
Dosage Form : Tetrofosmina 0.23Mg 2 Units Parenteral Use
Dosage Strength : 2 vials 0.23 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Myoview
Dosage Form : Tetrofosmina 0.23Mg 5 Units Parenteral Use
Dosage Strength : 5 vials 0.23 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Schedule C
Registration Country : Canada
Brand Name : MYOVIEW
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 0.23MG/VIAL
Packaging :
Approval Date :
Application Number : 2328755
Regulatory Info : Schedule C
Registration Country : Canada
Regulatory Info : Schedule C
Registration Country : Canada
Brand Name : MYOVIEW 30ML
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1.38MG/VIAL
Packaging :
Approval Date :
Application Number : 2422158
Regulatory Info : Schedule C
Registration Country : Canada
LOOKING FOR A SUPPLIER?